Literature DB >> 29383522

Staging liver fibrosis with DWI: is there an added value for diffusion kurtosis imaging?

Li Yang1, Shengxiang Rao1, Wentao Wang1, Caizhong Chen1, Ying Ding1, Chun Yang1, Robert Grimm2, Xu Yan3, Caixia Fu4, Mengsu Zeng5.   

Abstract

OBJECTIVES: To assess liver fibrosis in patients with chronic liver disease using diffusion kurtosis imaging (DKI) in comparison with conventional diffusion-weighted imaging, with histology as reference standard.
METHODS: This prospective study included 81 patients and DKI with b-values of 0, 200, 500, 1,000, 1,500, 2,000 s/mm2 were performed. Mean diffusivity (MD), mean kurtosis (MK) and apparent diffusion coefficient (ADC) maps were calculated. The diagnostic efficacy of MD, MK and ADC for predicting stage 2 fibrosis or greater, and stage 3 fibrosis or greater were compared.
RESULTS: The MD (rho=-0.491, p<0.001), MK (rho=0.537, p<0.001) and ADC (rho=-0.496, p<0.001) correlated significantly with fibrosis stages, and ADC exhibited a strong negative correlation with MK (rho=-0.968; p<0.001) and a moderate association with MD (rho=0.601, p<0.001). Areas under the curves (AUCs) for predicting stage 2 fibrosis or greater were not significantly different (p>0.05) between MK (0.809) and ADC (0.797) as well as between MD (0.715) and ADC. AUCs were also similar for MD (0.710), MK (0.768) and ADC (0.747) for predicting stage 3 fibrosis or greater.
CONCLUSION: Although DKI is feasible for predicting liver fibrosis in patients with chronic liver disease, MD and MK offer similar diagnostic performance to ADC values. KEY POINTS: • Diffusion kurtosis imaging is feasible for staging liver fibrosis. • Diffusion kurtosis and monoexponential model are highly correlated. • The kurtosis model offers no added value to the conventional, monoexponential model.

Entities:  

Keywords:  Diagnostic imaging; Diffusion-weighted MRI; Liver disease; Liver fibrosis; Magnetic resonance imaging

Mesh:

Year:  2018        PMID: 29383522     DOI: 10.1007/s00330-017-5245-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  34 in total

1.  Utility of diffusion-weighted imaging in the evaluation of liver fibrosis.

Authors:  Ayse Ahsen Bakan; Ercan Inci; Selim Bakan; Suut Gokturk; Tan Cimilli
Journal:  Eur Radiol       Date:  2011-10-09       Impact factor: 5.315

Review 2.  Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis.

Authors:  Siddharth Singh; Sudhakar K Venkatesh; Rohit Loomba; Zhen Wang; Claude Sirlin; Jun Chen; Meng Yin; Frank H Miller; Russell N Low; Tarek Hassanein; Edmund M Godfrey; Patrick Asbach; Mohammad Hassan Murad; David J Lomas; Jayant A Talwalkar; Richard L Ehman
Journal:  Eur Radiol       Date:  2015-08-28       Impact factor: 5.315

3.  Breast Cancer: Diffusion Kurtosis MR Imaging-Diagnostic Accuracy and Correlation with Clinical-Pathologic Factors.

Authors:  Kun Sun; Xiaosong Chen; Weimin Chai; Xiaochun Fei; Caixia Fu; Xu Yan; Ying Zhan; Kemin Chen; Kunwei Shen; Fuhua Yan
Journal:  Radiology       Date:  2015-05-04       Impact factor: 11.105

Review 4.  Diffusion-weighted MR imaging of the liver.

Authors:  Bachir Taouli; Dow-Mu Koh
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

5.  Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade.

Authors:  Kiminori Fujimoto; Tatsuyuki Tonan; Sanae Azuma; Masayoshi Kage; Osamu Nakashima; Takeshi Johkoh; Naofumi Hayabuchi; Koji Okuda; Takumi Kawaguchi; Michio Sata; Aliya Qayyum
Journal:  Radiology       Date:  2011-01-19       Impact factor: 11.105

6.  EASL Recommendations on Treatment of Hepatitis C 2015.

Authors: 
Journal:  J Hepatol       Date:  2015-04-21       Impact factor: 25.083

7.  Hepatic Fibrosis, Inflammation, and Steatosis: Influence on the MR Viscoelastic and Diffusion Parameters in Patients with Chronic Liver Disease.

Authors:  Helena S Leitão; Sabrina Doblas; Philippe Garteiser; Gaspard d'Assignies; Valérie Paradis; Feryel Mouri; Carlos F G C Geraldes; Maxime Ronot; Bernard E Van Beers
Journal:  Radiology       Date:  2016-10-27       Impact factor: 11.105

8.  Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations.

Authors:  Haruo Watanabe; Masayuki Kanematsu; Satoshi Goshima; Hiroshi Kondo; Minoru Onozuka; Noriyuki Moriyama; Kyongtae T Bae
Journal:  Radiology       Date:  2011-01-19       Impact factor: 11.105

9.  Stiffness Value and Serum Biomarkers in Liver Fibrosis Staging: Study in Large Surgical Specimens in Patients with Chronic Hepatitis B.

Authors:  Qiang Lu; Changli Lu; Jiawu Li; Wenwu Ling; Xiaoying Qi; Du He; Jianping Liu; Tianfu Wen; Hong Wu; Hongguang Zhu; Yan Luo
Journal:  Radiology       Date:  2016-02-17       Impact factor: 11.105

10.  Gadoxetic acid-enhanced MRI and sonoelastography: non-invasive assessments of chemoprevention of liver fibrosis in thioacetamide-induced rats with Sho-Saiko-To.

Authors:  Ya-Wen Chen; Meng-Yuan Tsai; Huay-Ben Pan; Hui-Hwa Tseng; Yu-Ting Hung; Chen-Pin Chou
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

View more
  7 in total

Review 1.  Magnetic Resonance imaging analysis of liver fibrosis and inflammation: overwhelming gray zones restrict clinical use.

Authors:  D Marti-Aguado; A Rodríguez-Ortega; A Alberich-Bayarri; L Marti-Bonmati
Journal:  Abdom Radiol (NY)       Date:  2020-08-28

2.  Differentiating between malignant and benign renal tumors: do IVIM and diffusion kurtosis imaging perform better than DWI?

Authors:  Yuqin Ding; Qinxuan Tan; Wei Mao; Chenchen Dai; Xiaoyi Hu; Jun Hou; Mengsu Zeng; Jianjun Zhou
Journal:  Eur Radiol       Date:  2019-06-03       Impact factor: 5.315

3.  Quantitative diffusion MRI of the abdomen and pelvis.

Authors:  Diego Hernando; Yuxin Zhang; Ali Pirasteh
Journal:  Med Phys       Date:  2021-10-08       Impact factor: 4.506

4.  Magnetic Resonance Diffusion Kurtosis Imaging versus Diffusion-Weighted Imaging in Evaluating the Pathological Grade of Hepatocellular Carcinoma.

Authors:  Guang-Zhi Wang; Ling-Fei Guo; Gui-Hua Gao; Yao Li; Xi-Zhen Wang; Zhen-Guo Yuan
Journal:  Cancer Manag Res       Date:  2020-06-29       Impact factor: 3.989

5.  Value of intravoxel incoherent motion in detecting and staging liver fibrosis: A meta-analysis.

Authors:  Zheng Ye; Yi Wei; Jie Chen; Shan Yao; Bin Song
Journal:  World J Gastroenterol       Date:  2020-06-21       Impact factor: 5.742

6.  Diffusion MRI signal cumulants and hepatocyte microstructure at fixed diffusion time: Insights from simulations, 9.4T imaging, and histology.

Authors:  Francesco Grussu; Kinga Bernatowicz; Irene Casanova-Salas; Natalia Castro; Paolo Nuciforo; Joaquin Mateo; Ignasi Barba; Raquel Perez-Lopez
Journal:  Magn Reson Med       Date:  2022-02-18       Impact factor: 3.737

7.  Feasibility study of simultaneous multislice diffusion kurtosis imaging with different acceleration factors in the liver.

Authors:  Hui Xu; Nan Zhang; Da-Wei Yang; Ahong Ren; Hao Ren; Qian Zhang; Jin-Xia Zhu; Gui-Jin Li; Zheng-Han Yang
Journal:  BMC Med Imaging       Date:  2021-09-09       Impact factor: 1.930

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.